2011 was a break-out year for deals between pharmaceutical companies and payers, with three major drug makers – AstraZeneca PLC, Sanofi and Pfizer Inc. – inking broad alliances with the research departments of Anthem Inc., Medco Health Solutions Inc. (now a part of Express Scripts Holding Co.), and Humana Inc.
The alliances signal that even as drug makers reorient their R&D engines to be more flexible and externally focused in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?